News and Resources

News and resources

How the Netherlands uses innovative finance to drive global health equity*

23 Sep 2025

In the world of global health financing, the Netherlands has provided strategic support for the International Finance Facility for Immunisation (IFFIm) and is a perfect example of how smart, focused investments can deliver powerful results.

Innovative finance at the core: Ken Lay spotlights the evolution of vaccine bonds at Gavi Global Summit

23 Sep 2025

At the recent Global Summit: Health & Prosperity through Immunisation, IFFIm Board Chair Ken Lay joined an influential panel exploring the future of financing for global immunisation.

Norway’s quiet power move: how a founding donor Is driving global health through innovative finance*

23 Sep 2025

When Norway joined the International Finance Facility for Immunisation (IFFIm) as a founding member in 2006, the idea of using the capital markets to fund vaccines was still a bold experiment. 

Uganda’s malaria vaccination programme is picking up pace

08 Sep 2025

Families and health leaders say community health workers deserve much of the credit for rising uptake.By John Musenze

In Kenya, a decade of rotavirus vaccination translates to a drop in childhood mortality

04 Aug 2025

Not only are fewer children being hospitalised with severe diarrhoea, but the vaccine’s evident impact is boosting confidence in immunisation generally, experts say.By Joseph Maina

Statement about IFFIm and Gavi replenishment

14 Jul 2025

Gavi, the Vaccine Alliance, has successfully concluded the replenishment event for its next strategic period (2026-2030), securing more than US$ 9 billion towards a target budget of US$ 11.9 billion. Gavi anticipates additional commitments in the coming months. Coming as it has in a complex period for sovereigns’ financing of health, clim...

IFFIm sterling bond takes total vaccine bond issuance over US$ 10 billion milestone

11 Jun 2025

The International Finance Facility for Immunisation (IFFIm) today announced the settlement of its £300 million, 3-year 4.25% fixed-rate bond that was announced on 3 June.  This is the third bond issue in pound sterling and a powerful reaffirmation of investor confidence in vaccine bonds as a tool for global health impact. With this latest...